Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • E-News Sign Up
  • My Cart
  • Transplant Benefits & Coverage
    • Transplant Indications and Outcomes
    • Understanding Unrelated Donor Search
    • Benefit Design for HCT
    • HCT Cost and Coverage
  • Resources & Education
  • Understanding Transplant
    • HCT 101
    • Defining Quality in HCT
    • Coding and Billing Resources
    • Health Professional Educational Resources
  • Stay Connected
    • HCT Enews
    • Contact Us
  • Payer Initiatives
    • Payer Forums
  • HCT 101
  • Defining Quality in HCT
  • Coding and Billing Resources
  • Health Professional Educational Resources

Defining Quality in HCT


  • Understanding Transplant
  • Defining Quality in HCT
  • Email
  • Print This Page

Defining Quality in HCT

Health care systems in the U.S. and worldwide face enormous pressure from rising costs, demand for care, quality improvement, and innovation in care delivery and payment models.

Learn about current quality measures in HCT and what industry stakeholders recommend for the future.

Measures of Today: Outcomes and Cost 

To date, the effectiveness of HCT has only been measured by patient 1-year outcomes. While this is an important measure, Medicare and other payers are moving towards expanded pay for value programs and reimbursement models which will require additional ways to quantify the quality and outcomes of HCT.

Learn more about value based purchasing goals of the future.

Defining Quality and Value in the Future

The NMDP/Be The Match is leading a broad base of individuals and health care organizations – including physicians, transplant recipients, HCT program administrators, national payers, reinsurers, and researchers to expand thinking around how to demonstrate that HCT is an appropriate, cost-effective, and high-quality treatment option for a wide range of diseases. 

These leaders believe that in addition to outcomes, quality and value in HCT will be best demonstrated by also measuring performance in the following areas:

  • Email
  • Print This Page

About Us

  • What We Do
  • Global Transplant Network
  • Our History
  • Leadership
  • Careers
  • About Our Research

Our Websites

bethematch.org
BeTheMatch.org Information and support for patients, donors and supporters of our mission.
BeTheMatchBioTherapies.com
BeTheMatchBioTherapies.com Proven solutions for organizations developing and delivering new cellular therapies
CIBMTR.org
CIBMTR.org Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2023 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright